A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Pfizer Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 1,796,648 shares of PFE stock, worth $52.3 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
1,796,648
Previous 1,777,793 1.06%
Holding current value
$52.3 Million
Previous $49.4 Billion 99.9%
% of portfolio
0.29%
Previous 0.36%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $476,277 - $558,108
18,855 Added 1.06%
1,796,648 $50.3 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $46 Million - $52.9 Million
1,777,793 New
1,777,793 $49.4 Billion
Q4 2023

Aug 14, 2024

SELL
$26.13 - $33.94 $47,739 - $62,008
-1,827 Reduced 0.15%
1,183,577 $34.1 Billion
Q3 2023

Aug 14, 2024

BUY
$32.09 - $37.51 $5.37 Million - $6.28 Million
167,483 Added 16.45%
1,185,404 $39.3 Billion
Q2 2023

Aug 14, 2024

BUY
$36.12 - $41.79 $3.28 Million - $3.79 Million
90,766 Added 9.79%
1,017,921 $37.3 Billion
Q1 2023

Aug 14, 2024

SELL
$39.39 - $51.28 $124,511 - $162,096
-3,161 Reduced 0.34%
927,155 $37.8 Billion
Q4 2022

Aug 14, 2024

SELL
$41.75 - $54.5 $272,794 - $356,103
-6,534 Reduced 0.7%
930,316 $47.7 Billion
Q3 2022

Aug 14, 2024

SELL
$43.76 - $53.42 $748,602 - $913,855
-17,107 Reduced 1.79%
936,850 $41 Billion
Q2 2022

Aug 14, 2024

BUY
$46.53 - $55.17 $881,557 - $1.05 Million
18,946 Added 2.03%
953,957 $50 Billion
Q1 2022

Aug 14, 2024

SELL
$45.75 - $56.69 $39.4 Million - $48.8 Million
-861,637 Reduced 47.96%
935,011 $48.4 Billion
Q4 2021

Aug 30, 2024

BUY
$41.32 - $61.25 $197,633 - $292,958
4,783 Added 0.52%
930,399 $54.9 Billion
Q3 2021

Aug 30, 2024

SELL
$39.25 - $50.42 $7.03 Million - $9.03 Million
-179,001 Reduced 16.2%
925,616 $39.8 Billion
Q2 2021

Aug 30, 2024

SELL
$35.91 - $40.68 $24.9 Million - $28.2 Million
-692,031 Reduced 38.52%
1,104,617 $43.3 Billion
Q1 2021

Aug 30, 2024

BUY
$33.49 - $37.77 $2.32 Million - $2.62 Million
69,306 Added 9.14%
827,347 $30 Billion
Q4 2020

Aug 30, 2024

BUY
$33.47 - $42.56 $5.66 Million - $7.19 Million
168,963 Added 28.68%
758,041 $27.9 Billion
Q3 2020

Aug 30, 2024

SELL
$31.75 - $37.25 $1.68 Million - $1.98 Million
-53,065 Reduced 8.26%
589,078 $21.6 Billion
Q2 2020

Aug 30, 2024

BUY
$30.12 - $36.54 $1.63 Million - $1.98 Million
54,168 Added 9.21%
642,143 $21 Billion
Q1 2020

Aug 30, 2024

BUY
$27.03 - $38.62 $2.62 Million - $3.74 Million
96,895 Added 19.73%
587,975 $19.2 Billion
Q4 2019

Aug 30, 2024

BUY
$32.92 - $37.36 $2.7 Million - $3.07 Million
82,068 Added 20.06%
491,080 $19.2 Billion
Q3 2019

Aug 30, 2024

BUY
$32.49 - $42.13 $2.26 Million - $2.93 Million
69,633 Added 20.52%
409,012 $14.7 Billion
Q2 2019

Aug 30, 2024

SELL
$36.98 - $41.52 $1.03 Million - $1.16 Million
-27,940 Reduced 7.61%
339,379 $14.7 Billion
Q1 2019

Aug 30, 2024

SELL
$37.5 - $41.2 $15.6 Million - $17.1 Million
-414,835 Reduced 53.04%
367,319 $15.6 Billion
Q4 2018

Aug 30, 2024

SELL
$38.47 - $43.86 $39 Million - $44.5 Million
-1,014,494 Reduced 56.47%
782,154 $34.1 Billion
Q3 2018

Aug 30, 2024

SELL
$34.47 - $41.81 $893,255 - $1.08 Million
-25,914 Reduced 2.65%
950,581 $41.9 Billion
Q2 2018

Aug 30, 2024

BUY
$32.98 - $35.16 $1.08 Million - $1.15 Million
32,841 Added 3.48%
976,495 $35.4 Billion
Q1 2018

Aug 30, 2024

BUY
$31.91 - $37.02 $1.86 Million - $2.15 Million
58,160 Added 6.57%
943,654 $33.5 Billion
Q4 2017

Aug 30, 2024

BUY
$33.26 - $35.29 $38,614 - $40,971
1,161 Added 0.13%
885,494 $32.1 Billion
Q3 2017

Aug 30, 2024

BUY
$31.0 - $34.15 $158,069 - $174,130
5,099 Added 0.58%
884,333 $31.6 Billion
Q2 2017

Aug 30, 2024

BUY
N/A
845,472 Added 2504.21%
879,234 $29.5 Billion
Q1 2017

Aug 30, 2024

SELL
N/A
-1,762,886
33,762 $1.15 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.